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Summary
The decline in CD4+ T cell function with aging contrib-
utes to reduced vaccine efficacy. In this commentary,
we discuss the factors leading to age-related changes
in T cell function and propose how they may be over-
come to enhance vaccine efficacy for the elderly.
Introduction
As individuals age, infectious diseases cause increasing
morbidity and mortality. In fact, declines in immune func-
tion are a hallmark of aging and result in the decreased
ability of the elderly to both resist infection and respond
to vaccination. This is especially evident when the el-
derly contract newly emerging diseases such as severe
acute respiratory syndrome (SARS), which killed 50%
of those over 50 years of age who were infected (Chen
et al., 2005). Yearly outbreaks of influenza virus kill
30–50 thousand per year (Thompson et al., 2003) and, if
the H5N1 bird flu should become more readily transmis-
sible, the elderly will likely be highly vulnerable.
In light of increasing elderly populations in Western
societies, it is critical that we understand what defects
in lymphoid cells are responsible for this decline in func-
tion, what mechanisms lead to impaired function, and
whether poor responses can be improved and/or over-
come so that strategies to increase vaccine efficacy
can be developed. Several functional defects in lym-
phoid cells that develop with age have been defined,
and they are sufficiently extensive to largely explain
the poor vaccination results. However, the cause of
these defects and whether they are intrinsic to the cells
or an extrinsic consequence of the milieu or history of
the individual lymphocytes is unclear.
Defects in Immunization in the Elderly
After a primary viral infection, cell-mediated immunity,
including cytotoxic T cell (CTL) functions, are thought
to play the largest role in viral clearance (Turner et al.,
2004). In contrast, in immunized individuals, protection
from infection is most often mediated by virus-specific
antibodies (Ab; Thompson et al., 2004). A major problem
is that current vaccines exhibit reduced efficacy in the
elderly, leading to a high rate of infections in vaccinated
individuals. For example, the yearly influenza vaccine
has only 40% to 60% efficacy in older individuals (Vu
et al., 2002). The elderly also have higher rates of compli-
cations such as congestive heart failure and pulmonary
disease, resulting in the increased rate of hospitalization
and death after influenza infection (Thompson et al.,
2004). In addition to influenza, reduced responses in
the elderly have been noted with vaccinations for
tetanus, encephalitis, hepatitis, and Streptococcus
*Correspondence: sswain@northnet.orgpneumoniae (Cook et al., 1987; Hainz et al., 2005;
Musher et al., 1986), all of which aim to aim to generate
a protective antibody response.
The decline in antibody production following vaccina-
tion in the elderly is the result of reduced antigen-spe-
cific B cell expansion and differentiation, leading to pro-
duction of reduced titers of antigen-specific IgG (Zheng
et al., 1997). Furthermore, the Abs that are produced are
of poor quality due to reduced class switching and re-
duced somatic mutation in the variable region genes re-
sulting in reduced affinity (Song et al., 1997). Thus, Abs
produced by older individuals have diminished ability
to neutralize and opsonize pathogens, resulting in less
protection from subsequent infection.
The generation of high-affinity Ab occurs in germinal
centers (GCs), and, importantly, formation of GCs after
priming declines with aging (Zheng et al., 1997). The
generation of memory B cells, which is also essential
for vaccine efficacy, is also highly dependent upon GC
(Tsiagbe et al., 1996) and thus, is also reduced with
aging. The formation of GC, although not totally under-
stood at this time, is dependent upon CD4+ T cell help
and their cognate interaction with B cells. In addition
to sustained T-B cell contact, cytokine production by
CD4+ T cells is thought to be essential for robust help
(Tsiagbe et al., 1996). Thus, age-related changes in
CD4+ T cell and/or B cell function are likely to adversely
impact the outcome of a humoral response and they
may synergize to undermine immunity in the aged.
Defects in T Cells with Aging
One of the most notable changes in the peripheral T cell
compartment with aging is the decline in the number of
naive T cells in favor of cells with a memory phenotype
(Ernst et al., 1990). The ability of naive T cells from aged
animals to proliferate and produce cytokines is reduced
substantially (Haynes et al., 1999). Studies by Miller and
Garcia, using T cell receptor transgenic (TCR Tg) mice,
show that CD4+ T cells from aged mice do not form im-
munological synapses as readily as those from younger
mice upon stimulation with antigen and antigen present-
ing cells (Ag-APC; Garcia and Miller, 1997). Furthermore,
there is a marked reduction in the recruitment of TCR-
associated signaling molecules into the synapse when
aged naive CD4+ T cells interact with Ag-APC, which is
expected to lead to lower levels of initial TCR signals
and a reduction in many downstream events.
One functional defect that is of great consequence is
cytokine production. Naive CD4+ T cells from aged ani-
mals produce about half the IL-2 as young cells upon
initial stimulation with Ag-APC (Haynes et al., 1999).
This defect leads to less clonal expansion and reduced
differentiation of effector populations that produce re-
duced amounts of effector cytokines, with the exception
of interferon-g (IFN-g). Effectors generated from aged
naive CD4+ T cells express reduced activation and
differentiation markers such as CD25, CD62L, and
CD154, suggesting their differentiation is incomplete
(Eaton et al., 2004; Haynes et al., 1999). All of these de-
fects are overcome in vitro when IL-2 is provided (Hay-
nes et al., 1999), linking the set of defects to the reduced
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664Figure 1. Genesis of Aging Defects
We speculate that as CD4+ T cells develop
and differentiate, they develop defects in re-
sponsiveness and function that accumulate
and intensify with time, as indicated. These
can be divided into ‘‘developmental’’ defects
and ‘‘postthymic acquired defects,’’ as
shown. Some extrinsic factors, acting at var-
ious stages of T cell development, are pos-
tulated to have negative effects, including
exposure to oxidative and other stress, limi-
tations of survival factors, thymic atrophy,
and intrinsic factors such as increased age
of the individual cells and their repeated
homeostatic division. These are indicated in
the red box, and we suggest they combine
to undermine functionality. Stromal factors
in bone marrow and thymus may act to pre-
serve function. Whereas some defects may
be irreversible, others can be reversed or
muted by increasing extrinsic positive factors
such as survival and inflammatory cytokines,
as indicated by the blue box.production of IL-2 by the aged naive cells. There is also
a dramatic decline in the cognate helper activity of CD4+
T cells from aged individuals. CD4+ T cells from the aged
provide little cognate help for induction of humoral re-
sponses–leading to reduced B cell expansion, reduced
differentiation to GC phenotype and reduced IgG pro-
duction (Eaton et al., 2004; Zheng et al., 1997).
Memory T cells, generated from aged naive cells stim-
ulated in vitro even in the presence of IL-2, survive and
persist well, but they are markedly defective in prolifer-
ation and cytokine secretion in recall responses (Haynes
et al., 2003). Furthermore, memory cells derived from
aged naive CD4+ T cells are largely unable to provide
cognate help for humoral responses. Surprisingly, IL-2
treatment of defective memory cells cannot restore their
defect, suggesting the possibility of epigenetic changes.
Paradoxically, although naive CD4+ T cells from aged
individuals generate memory cells that are largely non-
functional, memory CD4+ T cells generated in young indi-
viduals have been shown to retain function for extended
periods of time as their host ages. This observation sug-
gests that only T cells at certain stages of development
are susceptible to induction of aging defects. Perhaps
functional memory needs to be generated in youth or
middle age unless strategies to more completely over-
come the defects of naive T cells in the elderly can be
developed.
Age-related declines in CD4+ T cell helper activity may
also cause defects in CD4+ T cell-dependent aspects of
CD8+ T cell responses. CD4+ T cells are critical for estab-
lishment and/or maintenance of the CD8+ T cell memory
pool probably via CD154 (Schoenberger et al., 1998).
CD8+ memory T cells generated without appropriate
CD4+ T cell help are defective in recall responses and
undergo activation-induced cell death upon reen-
counter with antigen. Naive CD4+ T cells from aged ani-
mals express less CD154 than young cells (Eaton et al.,
2004), and this may lead to the generation of fewer and
less enduring CD8+ T memory cells with greatly reduced
function, although this premise has not yet been directly
tested. We suggest that loss of naive CD4+ T cell func-
tion and consequent poor generation of Ab-producing
B cells, coupled with poor CD8+ T cell priming, synergizeto produce poor T and B cell effector function after pri-
mary immunization and poorly functional memory cells
of all types. This may explain both the inadequate re-
sponses of elderly patients to new pathogens they
have not encountered earlier in their lives as well as their
failure to be adequately vaccinated.
Genesis of T Cell Defects
Defects in naive CD4+ T cells seem to occur at multiple
levels. Production of new naive T cells declines dramat-
ically with age. This is probably due to intrinsic defects in
the stem cells or in the thymus itself (Min et al., 2004).
Because the size of the total peripheral T cell compart-
ment changes little, it is likely that the postthymic life
span of T cells must increase to maintain T cell numbers.
We have proposed that this longer residence of T cells
in the periphery with age contributes to the reduced
function (Haynes et al., 2005). Because persisting naive
T cells acquire this defect over time in the periphery, we
have termed this the ‘‘postthymic acquired defect’’ (Fig-
ure 1). It is easy to imagine that a series of factors could
work to erode T cell function over time. With aging, per-
sisting naive T cells, which divide slowly, if at all (Tough
and Sprent, 1994), will be exposed to extrinsic factors
such as oxidative stress, possible limitations in availabil-
ity of survival factors, and other unidentified environ-
mental factors. These factors may induce programs in
the T cells that favor persistence at the expense of future
function. To the extent the T cells do turnover, homeo-
static turnover itself may also limit their potential (Swain
et al., 2005).
Our studies support the idea that persistence in the
periphery leads to a progressive decrease in function.
New CD4+ T cells generated in aged animals from
aged stem cells function well in terms of proliferation
and IL-2 production (Haynes et al., 2005). Similar find-
ings are seen when CD4+ T cells are depleted in young
and aged TCR Tg mice by in vivo Ab treatment (Haynes
et al., 2005). After repopulation, new CD4+ T cells gener-
ated in aged mice proliferated and made IL-2 as well as
T cells from young animals. Equivalent results are found
when new polyclonal populations are generated in
young and aged nontransgenic mice. Newly generated
CD4+ T cells exhibit robust cognate function, leading
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665to enhanced humoral responses, again suggesting that
a portion of the aging defect is a result of postthymic
acquired defects.
Further support for this hypothesis of intensifying de-
fects acquired as T cells age comes from studies in
which the aging of the peripheral T cell population is
accelerated by thymectomy of young TCR Tg mice.
The cohort of T cells recovered from thymectomized
mice become less responsive starting at 8 months in-
stead of 14 months in sham thymectomized controls
(L.H. and S.L.S., unpublished data). Thus, halting pro-
duction of new T cells leads to reduced ex vivo response
of the remaining cells to Ag-APC. This defect could be
due to several factors, but it is compatible with the con-
cept that postthymic persistence leads to defects that
accumulate with time.
It is also possible that the renewed function of naive
T cells seen in the reconstitution models is in some
part due to the conditions under which they developed.
Indeed, defects in reconstitution potential are already
present in stem cells of aged mice, and these also are
expected because they too have been endured a longer
exposure to environmental stimuli. The frequency and
proliferation of early T lineage precursors (ETP) declines
with age (Min et al., 2004), leading to reduced pre-T cell
production. To evaluate the role of defects acquired dur-
ing development, we have examined whether T cells at
earlier stages of development exhibit some of the de-
fects seen later. We find that recent thymic emigrants
(RTE), which are likely to be derived largely from ETP,
exhibit age-related defects in proliferation and IL-2 pro-
duction, which we have termed the ‘‘developmental de-
fect’’ (K. Clise-Dwyer and S.L.S., unpublished data).
Thus, we propose that defects in CD4+ T cell function
with aging are the consequence of multiple defects that
occur at different stages of the T cell life span. One set of
defects (the developmental defect) occurs early before
the generation of RTE and another (the postthymic ac-
quired defect) occurs much later, after a lengthy stay
in the peripheral environment. This accumulation of de-
fects at several stages of the CD4+ T cell life span, as
a result of multiple extrinsic and intrinsic factors, is illus-
trated in Figure 1. Importantly, at least some of the func-
tional defects can be overcome by a variety of factors
discussed below.
Overcoming Aging Defects: Promise of Adjuvants
Importantly, extrinsic factors may be able to enhance
aged T cell function or reverse defects, suggesting
that some aging defects are either reversible or that their
impact could be muted by adding such factors (Haynes
et al., 1999, 2004). Both survival factors such as IL-2 and
inflammatory cytokines can markedly augment re-
sponses of aged naive cells both in vitro and in vivo.
One of the most clinically important age-related
changes in immune function is the decline in efficacy
of vaccinations. A straightforward approach to enhanc-
ing vaccine efficacy is to employ more potent adjuvants.
Adjuvants work, in part, by improving the activation of
APCs. APCs express toll-like receptors (TLR), which
have the ability to sense pathogen-associated molecu-
lar patterns from various kinds of pathogens (bacterial,
viral, parasitic; Iwasaki and Medzhitov, 2004). One of
the most promising TLR binding adjuvants is prokary-
otic unmethylated CpG containing oligodeoxynucleo-tide (CpG-ODN; Klinman, 2004). Studies have shown
that using CpG-ODN as an adjuvant can enhance the
response to vaccination in aged animals and boost Ab
production (Maletto et al., 2005). Many TLR binding ad-
juvants also induce APC to produce inflammatory cyto-
kines such as TNFa, IL-1, and IL-6 (Iwasaki and Medzhi-
tov, 2004), which can also enhance the function of naive
CD4+ T cells from aged animals. This enhanced function
includes improved clonal expansion and IL-2 production
(Haynes et al., 2004) and also enhanced cognate helper
function, leading to increased Ab production (L.H., S.
Eaton, and A. Maue, unpublished data). Thus, residual
functions of ‘‘defective’’ aged naive CD4+ T cells can
be improved, leading to enhanced vaccine efficacy.
When the pathways involved in enhancement of function
are defined, it should be possible to use TLR agonists
that stimulate particular pathways or other agonists of
pattern recognition receptors to make vaccines custom-
ized for the elderly.
It is also important to note that we believe that en-
hancing aged CD4+ T cell function alone will lead to im-
proved Ab production. Young CD4+ T cells transferred
into immunized aged hosts function well, resulting in ro-
bust humoral responses (Eaton et al., 2004). Thus, other
components of the humoral immune response, such as
B cells and follicular dendritic cells, do not lose function
with aging as dramatically as T cells. In addition, APCs,
such as dendritic cells, also do not seem to decline in
function with aging. Dendritic cells from young and
aged mice produce similar levels of inflammatory cyto-
kines in response to TLR ligands (R. Larson and L.H., un-
published data), and CpG-stimulated dendritic cells can
dramatically boost the in vitro responses of aged CD4+
T cells (S. Jones and S.L.S., unpublished data). In the
future, it will be interesting to determine if there is a direct
link between the observation that inflammatory cyto-
kines overcome aging defects in CD4+ T cell function
during an immune response and that generation of
new CD4+ T cells in a highly lymphopenic, possibly in-
flamed, environment (see Figure 1) overcomes some of
the defects in RTE developing in intact aged mice.
Questions for the Future
Some aspects of aging are readily explained by known
factors that result in decreased numbers of peripheral
naive lymphocytes, such as decreased stem cell activity
and decreased thymic output. However, we have little
understanding of why aged naive lymphoid cells fail or
explanations why some cells, like memory cells, seem
to escape the impact of prolonged survival. We also
do not understand what molecular changes in the lym-
phocytes are responsible for their impaired function. If
we can begin to understand the factors that induce ag-
ing defects and in turn define what these defects are, it
may be possible to design multiple new strategies to
compensate for the defects. It is especially important
to thoroughly evaluate how well and for how long adju-
vants can improve the responses of aged T cells.
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